712 related articles for article (PubMed ID: 19941237)
21. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
Bartalena L
Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic orbital decompression for Graves' ophthalmopathy.
Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
[TBL] [Abstract][Full Text] [Related]
23. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
[TBL] [Abstract][Full Text] [Related]
24. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients.
Baldeschi L; Wakelkamp IM; Lindeboom R; Prummel MF; Wiersinga WM
Ophthalmology; 2006 May; 113(5):874-8. PubMed ID: 16530839
[TBL] [Abstract][Full Text] [Related]
25. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
[No Abstract] [Full Text] [Related]
26. [Graves' ophthalmopathy].
Badelon I; Morax S
Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
[TBL] [Abstract][Full Text] [Related]
27. A questionnaire survey on the management of Graves' orbitopathy in Europe.
; Perros P; Baldeschi L; Boboridis K; Dickinson AJ; Hullo A; Kahaly GJ; Kendall-Taylor P; Krassas GE; Lane CM; Lazarus JH; Marcocci C; Marino M; Mourits MP; Nardi M; Orgiazzi J; Pinchera A; Pitz S; Prummel MF; Wiersinga WM
Eur J Endocrinol; 2006 Aug; 155(2):207-11. PubMed ID: 16868132
[TBL] [Abstract][Full Text] [Related]
28. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
[TBL] [Abstract][Full Text] [Related]
29. Graves orbitopathy: update on diagnosis and therapy.
Melcescu E; Horton WB; Kim D; Vijayakumar V; Corbett JJ; Crowder KW; Pitman KT; Uwaifo GI; Koch CA
South Med J; 2014 Jan; 107(1):34-43. PubMed ID: 24389785
[TBL] [Abstract][Full Text] [Related]
30. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy.
Sundar G; Chiam N; Lun K; Koh V
Orbit; 2014 Oct; 33(5):319-25. PubMed ID: 25121573
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
[TBL] [Abstract][Full Text] [Related]
32. Natural history of graves' orbitopathy after treatment.
Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
[TBL] [Abstract][Full Text] [Related]
33. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
Perros P; Žarković M; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi A; Bournaud C; Brix TH; Covelli D; Ćirić S; Daumerie C; Eckstein A; Fichter N; Führer D; Hegedüs L; Kahaly GJ; Konuk O; Lareida J; Lazarus J; Leo M; Mathiopoulou L; Menconi F; Morris D; Okosieme O; Orgiazzi J; Pitz S; Salvi M; Vardanian-Vartin C; Wiersinga W; Bernard M; Clarke L; Currò N; Dayan C; Dickinson J; Knežević M; Lane C; Marcocci C; Marinò M; Möller L; Nardi M; Neoh C; Pearce S; von Arx G; Törüner FB
Br J Ophthalmol; 2015 Nov; 99(11):1531-5. PubMed ID: 25953846
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and management of Graves' orbitopathy.
Lee HB; Rodgers IR; Woog JJ
Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
[TBL] [Abstract][Full Text] [Related]
35. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic orbital decompression for Graves' ophthalmopathy.
Kasperbauer JL; Hinkley L
Am J Rhinol; 2005; 19(6):603-6. PubMed ID: 16402649
[TBL] [Abstract][Full Text] [Related]
37. [Management of patient with Gaves' orbitopathy].
Di Fiore A; Paone L; Rendina R; D'Armiento E; Coccaro C; Alessandrini S; Marenco M; Ulisse S
Clin Ter; 2012 Nov; 163(6):e463-74. PubMed ID: 23306763
[TBL] [Abstract][Full Text] [Related]
38. [Decompression surgery for endocrine orbitopathy].
Kahaly GJ; Bumb P; Pitz S; Scheurle C; Ponto KA; Lingl K; Hommel G; Müller-Forell W; Weber MM; Mann WJ
Med Klin (Munich); 2007 Sep; 102(9):714-9. PubMed ID: 17879009
[TBL] [Abstract][Full Text] [Related]
39. [Graves' orbitopathy].
Eckstein A; Möller L; Führer D; Oeverhaus M
Dtsch Med Wochenschr; 2021 Oct; 146(20):1344-1351. PubMed ID: 34644795
[TBL] [Abstract][Full Text] [Related]
40. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
Wiersinga WM
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
